The ORL1 receptor: Molecular pharmacology and signalling mechanisms

David C. New, Yung H. Wong*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The cloning of the opioid-receptor-like 1 (ORL1) receptor and the identification of nociceptin as its endogenous agonist have revealed a new G-protein-coupled receptor signalling system. The structural and functional homology of ORL1 to the opioid receptor systems has posed a number of challenges in understanding the often competing physiological responses elicited by these G-protein-coupled receptors. Thus, this review will attempt to summarize recent research by many groups that has revealed numerous subtleties of the ORL1 receptor and its signalling pathways, as well as document the efforts to produce high-affinity selective ligands for the ORL1 receptor that may be of value as research and therapeutic tools.

Original languageEnglish
Pages (from-to)197-212
Number of pages16
JournalNeuroSignals
Volume11
Issue number4
DOIs
Publication statusPublished - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • G proteins
  • Nociceptin
  • ORL
  • Pharmacology, ORL receptor
  • Receptor structure
  • Signalling pathways

Fingerprint

Dive into the research topics of 'The ORL1 receptor: Molecular pharmacology and signalling mechanisms'. Together they form a unique fingerprint.

Cite this